Impact of codeine rescheduling on prescribing of codeine and other opioids: Interrupted time series analyses using Australian general practice data

IF 3.1 3区医学 Q2 PHARMACOLOGY & PHARMACY

British journal of clinical pharmacology Pub Date : 2024-09-19 DOI:10.1111/bcp.16246

Helena Cangadis-Douglass, Ting Xia, J. Simon Bell, Suzanne Nielsen

引用次数: 0

Abstract

We aimed to determine the impact of codeine rescheduling on prescribing of codeine and other opioids, with a focus on demographic and diagnoses associated with codeine prescribing before and after rescheduling of codeine to prescription-only in February 2018.

查看原文本刊更多论文

可待因重新上市对开具可待因和其他阿片类药物处方的影响：利用澳大利亚全科医生数据进行的间断时间序列分析

我们旨在确定可待因重新列表对可待因和其他阿片类药物处方的影响，重点关注 2018 年 2 月将可待因重新列表为处方药前后与可待因处方相关的人口统计学和诊断。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

British journal of clinical pharmacology 医学-药学

CiteScore

6.30

自引率

8.80%

发文量

419

审稿时长

1 months

期刊介绍： Published on behalf of the British Pharmacological Society, the British Journal of Clinical Pharmacology features papers and reports on all aspects of drug action in humans: review articles, mini review articles, original papers, commentaries, editorials and letters. The Journal enjoys a wide readership, bridging the gap between the medical profession, clinical research and the pharmaceutical industry. It also publishes research on new methods, new drugs and new approaches to treatment. The Journal is recognised as one of the leading publications in its field. It is online only, publishes open access research through its OnlineOpen programme and is published monthly.